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Abstract
Background: Magnetic resonance imaging (MRI) of patients with implanted cardiac pacemakers is
generally contraindicated but some clinicians condone scanning certain patients. We assessed the
risk of inducing unintended cardiac stimulation by measuring electric fields (E) induced near lead
tips by a simulated MRI gradient system. The objectives of this study are to map magnetically
induced E near distal tips of leads in a saline tank to determine the spatial distribution and
magnitude of E and compare them with E induced by a pacemaker pulse generator (PG).
Methods: We mapped magnetically induced E with 0.1 mm resolution as close as 1 mm from lead
tips. We used probes with two straight electrodes (e.g. wire diameter of 0.2 mm separated by 0.9
mm). We generated magnetic flux density (B) with a Helmholtz coil throughout 0.6% saline in a 24
cm diameter tank with (dB/dt) of 1 T/sec (1 kHz sinusoidal waveform). Separately, we measured E
near the tip of leads when connected to a PG set to a unipolar mode. Measurements were non-
invasive (not altering the leads or PG under study).
Results: When scaled to 30 T/s (a clinically relevant value), magnetically-induced E exceeded the
E produced by a PG. The magnetically-induced E only occurred when B was coincident with or
within 15 msec of implantable pacemaker's pulse.
Conclusions: Potentially hazardous situations are possible during an MR scan due to gradient
fields. Unintended stimulation can be induced via abandoned leads and leads connected to a pulse
generator with loss of hermetic seal at the connector. Also, pacemaker-dependent patients can
receive drastically altered pacing pulses.
Background
Magnetic Resonance Imaging (MRI) systems expose
patients and nearby clinical personnel to intense, low-fre-
quency, pulsed magnetic fields [1] as well as static mag-
netic fields and RF fields. The magnetic fields of interest in
this study are produced by the gradient coils and associ-
ated electronics. Most MRI systems produce magnetic
fields from three separate gradient fields with a maximum
rate of change (slew rate) of 30 T/s to 180 T/s. The fields
from each gradient coil are uniform in one plane (such as
a transverse slice of the body). These-fields induce electric
fields in conductive media such as patients' bodies in the
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bore of the magnetic resonance (MR) system or in the
bodies of persons close to the MR system. The induced
fields can cause nerve stimulation. If conductive wires are
in patients or nearby persons, the induced E-fields near
the ends of the wires will be many times greater than if the
wires were not present. For this reason among others,
patients are generally not allowed (by present practices) to
undergo MRI procedures if they have implanted cardiac
and neurological stimulations devices, or other medical
devices that consist, in part, of electrically-conductive
objects in their body. However, there is at present a trend
to produce medical implants that can be MRI compatible
so that patients with these implants could be imaged. In
addition, some advocate the scanning of patient with con-
ventional medical implants such as cardiac pacemakers,
using special protocols [2-4].
It is well known that when conductive (metal) objects in
the body or saline are exposed to time varying magnetic
fields the induced electric (E) fields are highest near sharp
edges and at the ends of conductive objects such as wires.
Results of many studies have been published on heating
at the ends of implanted wires and leads due to E-fields
induced by the RF coil of MRI systems [5-7]. This heating
is highly localized, i.e., focused within a few cubic millim-
eters and is therefore difficult to measure accurately [7].
However, there is little information published on the
magnitude and spatial distribution of the E-field sur-
rounding the tips of electrodes of medical implants such
as cardiac and neural stimulation leads in bodies of
patients exposed to MRI gradient fields. We performed
measurements in-vitro in a 24 cm diameter cylindrical
tank filled with saline (Fig. 1a) that served as a simple
model of the human torso. We exposed the saline tank
and various simulated and real cardiac pacemaker leads to
a simulated MRI gradient field [8]. The purpose was to
determine the magnitude and spatial distribution of the
E-field induced in the saline immediately adjacent to the
objects during exposures to simulated MRI gradient fields.
Compared to clinical exposures of patients, our induced
fields were higher for a given rate of change of B field. Our
exposure conditions were to a spatially uniform B field
and our patient model had a single value of conductivity
throughout. The results of these measurements enabled us
to estimate if the induced E-field at the tips of pacemaker
leads exceeded the therapeutic levels that are delivered to
patients by conventional cardiac pacemakers.
Background theory of magnetically induced 
electric fields in electrically conductive media
An E-field is induced in a volume of conductive medium
(such as a tank filed with saline solution or the human
body) whenever a time varying magnetic field passes
through the medium. The E-field is a vector quantity with
magnitude and direction. We used an exposure geometry
with a cylindrical container (Fig. 1) where the B field
(magnetic flux density) is perpendicular to the surface of
the saline in a tank. The saline conductivity was 1.0 S/m.
The resulting induced E-fields in the saline are in the form
of concentric circular rings, in a plane that is parallel to the
surface of the saline. The magnitude of the E-field
increases as the radial distance from the center increases.
The direction of the E-field vector is normal to a radial line
drawn for the center of the tank to the outer circumfer-
ence. The value of the E-field in the center of the tank is
zero. Equation 1 defines the root mean square (RMS)
magnitude of the E-field at any point in the saline induced
by a sinusoidally varying B field. This simple equation is
derived from Faraday's law and was verified using dipole
measurement system in a saline tank [9]. In this paper, the
E-field is an RMS value for all magnetically induced fields.
Where:
E = electric field at a point (V/m) in the saline
f = frequency (Hz) of the magnetic field
r = radial distance from center of saline (meter)
B = Magnetic flux density (Tesla)
When a conducting wire with or without insulation is
placed into a saline tank and exposed to a magnetic field,
a current is induced in the wire. If both ends of an insu-
lated wire have a small region of insulation removed this
will produce an enhanced E-field in the saline. The E-field
is greatest very close to the tip of the wire. The current den-
sity (J) at any point the surrounding saline is defined in
equation 2.
Where:
J = current density (amps/meter2)
σ = electrical conductivity of the saline (S/m)
E = RMS E-field at the point of interest (V/m)
If the proximal end is not in good electrical contact with
the saline, current will not be induced in the lead and very
little E-field will exist at the distal tip.
Ef r B =⋅⋅ ⋅ p (1)
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a. Saline tank and Helmholtz coil Figure 1
a. Saline tank and Helmholtz coil. b. Plastic support grid
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A time varying B field will induce a voltage (Vb) between
the two ends of a wire that is configured so it forms a loop
that is not completely closed (short circuit). Equation 3
defines the Vb induced across a gap between the ends of a
single turn loop of insulated wire, with only its ends not
insulated. The voltage is equal to the line integral of the E-
field over the path. This voltage is in turn equal to the inte-
gral of the component of the rate of change of the mag-
netic flux density that is normal to and passes through the
planar surface formed by the loop with an area A.
Where:
E = electric field (V/m)
dl = unit element of a closed loop
dB/dt = rate of change of the magnetic flux density
(Tesla/s)
dA = unit element of the area A
For the case of a thin, long conductive object submerged
in saline, the direction of the E vector induced by mag-
netic induction or by injected voltage is as follows. This
assumes the object is much more conductive than the sur-
rounding saline. The E-field vector points in a direction
normal to the surface of the conductor (Fig. 2). The con-
ductor is insulated except for the two "bare" ends. The fig-
ure is drawn in the x-y plane containing the 'center cut' of
the conductor. If the E-field is measured with a two-elec-
trode probe, then its magnitude and direction must be
determined by measuring each of the three components
of the field. This is done by taking three separate measure-
ments with the probe electrodes oriented in perpendicular
directions at the same point. Figure 3 shows two of the
three possible orthogonal orientations of the probe. The
third orientation is perpendicular to these two orienta-
tions in the Z direction. Once the separate components of
the E-field are measured, the vector sum can be calculated
to get the true magnitude of the field as shown in equation
4. For our symmetric system, the Z component of the E-
field is zero in the x-y plane containing the center cut of
the conductor. Therefore, we did not measure this compo-
nent. The Y component is zero anywhere along the central
axis of the conductor (X = 0, Z = 0) as long as the conduc-
tor is centered in the X-Y plane.
Where:
 = magnitude of the E vector and the x, y and z
components of the vector E are listed in the equation.
Methods
E-field probe
We measured E-fields with two versions of a two-electrode
probe made with solid conductor copper wires. The large
probe used American Wire Gauge (AWG) 24 with a diam-
eter of 0.5 mm. The small probe used AWG 32 wire with
a diameter of 0.2 mm. The tips of the wires of the large
probe were separated by 1.6 mm for the outside dimen-
sion and 0.6 mm for the inside dimension (Fig. 4). For the
small probe the outside and inside separations were 0.9
and 0.5 mm respectively. The wires were placed in a dis-
posable plastic, standard-tip, serological 10 mL graduated
pipette (length: 22.5 cm, inner diameter: 2.5 mm, outer
diameter: 4.5 mm). At the distal tip of the probe the bare
wires of each probe extended 3.5 mm from the tube and
were held in the tube with aquarium grade silicone gel.
Each probe had a twisted pair of insulated wires inside the
tube (the same wire that the probe was constructed with),
that extended 6 meters. These wires were connected at the
proximal end to a preamplifier of our data acquisition sys-
tem. The wires going from the glass tube to the preampli-
fier were oriented in a straight line parallel to the B field
vector of the gradient coil. For certain experiments we
needed to provide a reduction in the pickup of electric
fields in the measurement environment. For these meas-
urements we added an aluminum foil shield around the
glass tube and connected it to our measurement system
"ground".
Gradient field simulator
To generate a 1 kHz B field with 1.25 Gauss RMS (1.25 ×
10-4 T) we used a modified Helmholtz coil with an outer
diameter of 41.6 cm. This device has two single-turn coils
each made of copper tubing. The tubing diameter is 1.6
cm. The broad surfaces of the two coils were in parallel
planes separated by 14.6 cm (Fig. 1). The coils were con-
nected in parallel. This device was originally designed for
producing a spatially uniform field to test implanted med-
ical devices in saline for susceptibility to electromagnetic
interference [10]. The coil was driven by current from a
transconductance amplifier (Clarke-Hess, Medford, NY
11763, USA). The input to the amplifier was a 1 kHz sinu-
soidal voltage from a Hewlett Packard Arbitrary Wave-
form Generator (Model 33120A, Palo Alto CA, USA). The
B field throughout the volume between the coils was
measured with a magnetic field probe with dimensions of
3.7 × 3.7 × 10 cm (ERM model 1850, ERM Pittsburgh, PA,
USA). This field is linearly polarized and is intended to
provide a simplified but worst-case replica of one axis of
the gradient field used for a clinical MRI system with a
smaller diameter than a clinical MRI coil. Our field
VE d l
d
dt
Bd A b =⋅ = ⋅ ∫∫ v
(3)
E EEE xyz =+ +
222 (4)
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reverses polarity every 1 ms, creating a rate of change of B
that closely approximates a 1 T/s ramp at portions of the
sinusoid that are within ± 45 degrees of the zero crossings
of the waveform.
Our coil produced a spatially uniform B field (Z-oriented)
throughout a cylindrical volume. This allowed us to pro-
duce an induced E-field in the saline tank and surround-
ing the tip of a pacemaker lead that was well
characterized. Results of measurements made using this
simulator can be extrapolated to the E-field produced a
gradient coil of an MRI system. The sinusoidal field we
used differs from the gradient field of a clinical MRI in that
it is a continuous wave and not a series of pulses. How-
ever, the use of a sinusoid has the distinct advantage that
the induced E and J in saline tank can be calculated simply
and exactly. Another difference is that a clinical MRI sys-
tem has three gradient coils, each producing a magnetic
field in one of three orthogonal directions. These fields are
intentionally non-uniform in terms of the spatial distribu-
tion of the B field over the volume patient's body. How-
ever, most gradient coils produce a uniform B field in a
Cross section of the center of an insulated conductor with bare ends Figure 2
Cross section of the center of an insulated conductor with bare ends. The E- vector points in a direction normal to 
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single plane in the body, for example the plane containing
the entire lead of an implanted pacemaker. Our coil pro-
duces this condition and produces a worst-case situation
by producing a uniform field over the entire volume, not
just in a single plane in the body. Therefore, the entire
pacemaker lead is exposed to the maximum B field, which
may not be the case in a clinical situation.
Patient simulating tank
We used a cylindrical plastic tank, filled with saline to
evaluate the E-field induced in a patient's body (Fig. 1).
The tank had an inner diameter of 24 cm and a height of
22.7 cm and was centered inside the Helmholtz coil. The
tank was filled with saline (0.6% NaCl) to a depth of 15
cm. This produced a mixture with salinity in the physio-
logical range and having conductivity with a simple, con-
venient value of 1.0 S/m. The tank was constructed of clear
acrylic plastic cylinder 24.1 cm (9.5 in) outer diameter,
0.6 cm wall thickness (0.25 in), depth 24.1 cm (9.5 in). A
plastic support grid was mounted horizontally above the
bottom of the saline tank. The plastic grid was cut from a
fluorescent light fixture cover made of nonconductive
plastic which is cut to fit the box's opening so that the
grid's top surface is placed 9 cm above the bottom of the
tank on four plastic threaded bolts screwed into plastic
bolts on the grid. The grid is constructed of beams 0.2 cm
wide, 0.9 cm thick and spaced 1.4 cm apart. The grid walls
are 1.3 cm on a side. This grid was used for testing pace-
makers for electromagnetic interference in ANSI/AAMI
standard PC69 [11]. The leads and pulse generator of
pacemakers or implantable defibrillators rest on this grid.
A cutout on one location at the outer edge of the grid
(46.8 × 13.6 mm) removed all plastic from the immediate
proximity of the distal tip of a lead under test (Fig. 1b).
Probe scanner
Spatial mapping of E-fields was performed by moving the
probe in a straight line through areas of interest. We
scanned areas of interest in the saline tank using a SPEAG
DASY5 robotic Dosimetric Assessment System (Schmid &
Partner Engineering AG, Zeughausstrasse 43, CH - 8004
Zurich Switzerland) which is referred to in this paper as
the 'scanner'. This device has a 6-axis industrial robotic
arm with a 0.1 mm linear motion step size in three dimen-
sions and the capability to move and record tip location
anywhere within more than 100 cm × 50 cm horizontal
plane and vertically more than 100 cm. We scanned con-
tinuously at a constant speed in a single direction. For a
scan over a 10 mm linear path near a lead tip we set the
scanner to pause and take probe voltage readings every 0.1
mm. For scans across the entire diameter of the tank we set
the scanner to take readings every 2 mm. During each
pause, 15,000 voltage readings were taken and the RMS
value was computed over many cycles of the B field. The
probe was placed so the pipette holding the two wires of
the distal end was oriented in a vertical direction and the
Probe-tip orientation terminology is defined as follows Figure 3
Probe-tip orientation terminology is defined as follows. For each of these scans (perpendicular and parallel) we took 
data for two probe-tip orientations. a. scan perpendicular, probe tips normal to distal tip axis b. scan perpendicular, probe tips 
aligned to distal tip axis c. scan parallel, probe tips normal to distal tip axis d.  scan parallel , probe tips aligned to distal tip axis.
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The 2-electrode probe Figure 4
The 2-electrode probe.
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twisted pair of wires was also vertical (parallel to the B vec-
tor for minimum coupling). Linear scans were performed
in selected locations in a horizontal plane to measure the
E-field in the saline near the pacemaker leads as well as in
the saline with no leads present.
Data acquisition instrumentation
Our data acquisition system consisted of the following
hardware components. The probe output wires were fed
to a Grass model P55 AC Preamplifier (Grass technolo-
gies, West Warwick, RI 02893 U.S.A.). The amplifier was
used with a 300 - 3000 Hz bandpass setting and a gain of
1000. For certain measurements, when a pacemaker pulse
generator was connected to the leads under test, a DC to
3000 Hz passband was used. The signal out of the pream-
plifier was delivered to the SPEAG system signal input
consisting of a National Instruments PXI 6115 data acqui-
sition system with 4 analog input channels each with a 12-
bit analog to digital converter operating at 15,000 sam-
ples/second. The 1 kHz sinusoidal voltage output from
the probe and its pre-amplifier were converted to an RMS
value for each measurement point (nominally 0.1 mm).
For measurements of pacemaker pulse generator wave-
forms we used a digital oscilloscope (Lecroy, model
LS140, 700 Chestnut Ridge Road NY 10977-6499, USA)
instead of the SPEAG data acquisition system.
It should be noted that our probe and measurement sys-
tem may not be able to measure or estimate the magni-
tude of certain clinical gradient-field induced E-fields near
lead tips. Specifically pulses from clinical MRI systems
with very fast rise times will be attenuated by the bandpass
filters we used to reduce measurement noise.
Calibration of the E-field measurement probes
Calibration of the two-electrode probe was performed by
measuring the voltage across the two electrodes of our
probe (at the proximal end of the wires) when the distal
tip was placed in a region in the saline tank with a known
value of the E-field. We exposed the saline tank to a
known value of a 1 kHz B field (1.25 × 10-4 T) and then
calculated the induced E-field in a region where the spatial
distribution of the E-field was virtually constant, relative
to the probe electrode dimensions. The two probe elec-
trodes were oriented for maximum coupling with the E-
field. The calculated E-field was 0.047 V/m at the outer
edge of the saline (radius = 12 cm). The two-electrode
probe was then assigned a calibration factor based on the
measured voltage between the electrodes.
Another test was made to assess the quality of our E-probe
measurement system (including signal wires and pream-
plifiers). We measured the unwanted electromagnetic
pickup of voltages in the twisted pair of wires between the
probe's distal tip at one end and the preamplifier in the
measurement system at the other end. We determined this
unwanted pickup or interference by measuring the E-field
at the exact center of the saline tank. At this location the E-
field is zero (this corresponds to radial distance r = 0 in
Eqn. 1). In fact the measured value of the E-field with the
two-electrode probe was not distinguishable from the
noise level of our measurement system. This noise level
was less than 2% of the voltage measured at the outer edge
of the saline-filled tank. Therefore, we had a minimal
measurement artifact due to pickup.
Pacemaker leads
We used two pacemaker leads and a "simulated lead" in
our study. The leads were individually placed in a circular
arrangement on the support grid in the saline-filed tank.
For the simple, "simulated lead" we used a solid conduc-
tor copper wire, 0.6 mm diameter wire, (AWG 22), with
0.4 mm thick insulation, with a 54 cm length. The insula-
tion was removed for the last 5 mm of the proximal end.
The distal end was completely covered with insulation,
but this end was bluntly cut so that the circular cross sec-
tion of the end of the metallic wire was exposed to saline.
We found that a bluntly cut wire (rather than a wire with
an exposed conductor with length greater than 0.5 mm or
more) produced an E-field near the distal tip that was
much higher and was most similar to the E-field near the
tip of a real pacemaker lead.
We measured the E-field induced at the distal tip of this
simulated lead plus the distal tips of two commercially
produced pacemaker leads. One lead had a tined tip. This
was a Medtronic model number 5554 Capsure Z high
impedance atrial J lead with silicone insulation
(Medtronic, 710 Medtronic Parkway, Minneapolis, MN
55432-5604 USA). The lead was 54 cm long and had an
outer diameter of 1.6 mm. This lead was insulated except
for the electrode at the distal tip and a bipolar ring elec-
trode. The tip had an exposed electrically conductive hem-
isphere with a diameter of approximately 0.5 mm. The
proximal end had a solid metal connector in the shape of
a cylindrical rod that was used to insert and connect the
lead to a pacemaker pulse generator. This connector had a
diameter of 1.6 mm and a length of 5.2 mm. This lead had
a second bipolar ring electrode near the distal end that
was not evaluated in terms of magnetically induced E-
fields. We also measured the E-field at the end of a com-
mercially produced pacemaker lead with an active fixation
screw tip. This was a Guidant Fineline II lead, with poly-
urethane insulation (Boston Scientific Corporate Head-
quarters, One Boston Scientific Place, Natick, MA 01760-
1537 USA). This lead was 58.4 cm long and 1.5 mm diam-
eter. The active fixation tip was an extremely small helical
coil with a wire diameter of approximately 0.2 mm. TheBioMedical Engineering OnLine 2009, 8:39 http://www.biomedical-engineering-online.com/content/8/1/39
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proximal end had a solid metal connector (in the shape of
a cylindrical rod). The connector had a diameter of 1.6
mm and a length of 5.2 mm. For each of the commercial
pacemaker leads the metal connector at the proximal tip
was exposed to saline, creating a closed electrical path
(loop) so magnetically induced currents could flow
through both ends of the lead and the saline. The tips of
each commercially produced pacemaker lead are shown
in figure 5.
Lead configurations
We configured each of three leads (simulated, tined tip
and active fixation tip) in a circular loop with its insulated
conductor routed along the outer circumference of the
plastic grid in the saline tank with the same loop radius.
The simulated lead was configured in a circular path with
a diameter of 19.75 cm. The gap between the distal and
proximal ends for this loop was 5 cm. The area enclosed
by this loop is on the order of 300 square cm. This is sim-
ilar to the worst case loop area of 314 cm2 identified in the
AAMI pacemaker EMC standard [11].
Pacemaker pulse generator
For some experiments we used one of two cardiac pace-
maker pulse generators. One was a Medtronic KDR401 set
to unipolar pacing with a "typical" 0.5 V pulse. We also
used a Guidant "Insignia" pacemaker set to a "minimum"
pacing level of 0.1 V. The waveforms of the pulses are
illustrated in the results section of this paper. The genera-
tor was connected to the tined tip lead. This enabled us to
compare the absolute value of "injected" E-field in the
saline at the distal tip to the magnetically induced E-field
at this same location. The injected E-field is produced by
the pulse generator, in the lead via conduction. This
'injected" E-field represents what is produced in a patient
near the tip of when the gradient field is off, i.e., it is the
normal therapeutic stimulation. In contrast, the "magnet-
ically induced" E-field is produced by the gradient field.
Mapping magnetically induced E-fields
We used the scanning system and E probes to measure the
E-field along a series of linear paths that passed directly in
front of the distal tips of various pacemaker leads. We
used both the large and small probes to determine the
effects of probe tip size on sensitivity, measured spatial
resolution and field patterns. This location is where the E-
field is highest. We defined special terminology to
describe the path we used to scan the probe past a pace-
maker lead under test and to define the orientation of the
probe electrodes with respect to the pacemaker lead under
test (Fig. 3). We also defined a "distal tip axis" and a "probe-
tip orientation." Each lead was configured to lie in a plane
that was perpendicular to the B field vector. This would
induce the maximum voltage across the lead (Eqn. 3). For
each lead we scanned the probe along two different linear
paths past the distal tip. One scan was along a path that
was  parallel  to the "distal tip axis" (Fig. 3). This scan
started with the probe tip 11 mm from the distal tip of the
pacemaker and moves toward the tip, finishing 1 mm
from the tip. We also scanned along a path that was per-
pendicular to the "distal tip axis" with the closest distance
between probe tip and lead tip being 1 mm. The probe
location terminology we used is based on the dimension
between the nearest surface of the probe electrode tip and
the nearest surface of the pacemaker lead tip. This method
is non-invasive in terms of altering the leads or pulse gen-
erator under study.
Probe-tip orientation terminology is defined as follows:
For each of these scans (perpendicular and parallel), we
took data for two probe-tip orientations (Fig. 3). The
probe-tip orientations are termed normal  orientation and
aligned orientation to define the relationship with the dis-
tal tip axis of the pacemaker lead. The distance between
the closest point of the probe tip and the distal tip of the
pacemaker lead under test was 1 mm when it passed
directly by the lead tip in perpendicular and parallel ori-
entations. The vector magnitude of the E-field at each
point in the scan was calculated by computing the squared
value of the magnitude of the voltage at each point, for
each of the two probe tip orientations. Then the square
Pacemaker lead tips Figure 5
Pacemaker lead tips.
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root of the sum of the squares was computed to yield the
vector magnitude of the E-field (Eqn. 4). Measurement of
the third vector component (Z component) of the E-field
(in a direction parallel to the B field vector) was not
needed to determine the vector magnitude. This is
because the value of the Z component of the E-field is zero
in the plane that we placed the lead in.
Measuring injected E-fields from pacemaker pulse 
generator voltages
We measured the E-field magnitude versus time at a fixed
location, 1 mm from the distal tip of a lead with an active
fixation tip while the proximal end was connected to an
active pacemaker pulse generator (PG). This provided a
good reference for E-field waveforms and amplitudes that
are produced for clinically effective cardiac stimulation.
The probe tips were aligned parallel to the distal tip axis of
the lead. Two pacemaker pulse generators were used dur-
ing separate measurements to deliver two different stimu-
lation waveforms. The Medtronic KDR401 delivered 0.5 V
pulses and the Guidant "Insignia" delivered 0.1 V pulses
to a unipolar electrode configuration. We did not look at
bipolar stimulation since it is known that this configura-
tion produces less MRI magnetically-induced stimulation
than unipolar stimulation [12]. For most measurements
with pacemakers connected to a lead, the 1 kHz magnetic
field from our gradient field simulator was present along
with the pacemaker pulse. This allowed us to compare
simultaneously the E-field injected by the pulse generator
voltage with the E-field induced by the magnetic field. The
two E-fields (magnetically induced and pulse-generator
injected) could be partially separated by observing the
probe voltage in the time domain with our oscilloscope.
This method is non-invasive in terms of altering the leads
or pulse generator under study. The magnetic field was on
continuously, but the pulse generator was only on a frac-
tion of the time, with a regular pulse rate. When the pulse
generator was delivering a voltage, the E-field was a sum-
mation of the injected plus the magnetically induced
fields. The injected pulse was much larger and readily
observed. We also measured the E-field when only the
pacemaker pulse was being delivered to the lead while no
magnetic field was on. No unusual effects occurred for
this case versus the case when both magnetic and injected
E-fields occurred simultaneously.
E-field near the distal tip versus E-field induced in saline - 
the E-ratio
For each lead (with no PG connected), we measured the
vector magnitude of the E-field in saline with the probe 1
mm from the tip of the lead while the B field was on. We
then measured the vector magnitude of the E-field at the
same point with the lead removed from the saline
('empty' tank). We defined the E-ratio as the value of the
magnetically-induced E-field at the tip of a lead divided by
The E-field induced at this same location with no lead
present. This E-ratio provides a measure of the enhance-
ment of the E-field produced by a particular lead. The E-
ratio data are shown in Table 1 for measurements with the
large and the small probe. The absolute value of the E-
field in the saline with no pacemaker lead present is easily
calculated using equation 1. The E-field in the empty tank
with saline, at the location where the tip of a lead would
later be placed was 0.035 V/m. This information, along
with the E-ratio allows us to calculate the absolute value
of the E-field at the tip of a pacemaker lead.
Results
We evaluated our data on E-field distributions induced by
magnetic fields from our gradient field simulator. The E-
field distribution was measured around the tips of each of
the three real or simulated pacemaker leads. For one set of
measurements, no pacemaker pulse generator was con-
nected to the leads. The leads were configured in a loop
submerged in saline. We measured along the two scan
paths defined earlier; one that was parallel and one that
was perpendicular to the distal tip axis. For each scan path
the probe tips were oriented both normal to the distal tip
axis and aligned to the distal tip axis. The vector magni-
tude (calculated from Eqn. 4) of the voltage from each of
the two orientations was taken for each of the scans.
Spatial distribution of E-field near the distal tip - falloff 
distance and width
We measured the E-field distribution near the tips of three
leads by scanning our probe along two paths. One path
was parallel and the other was perpendicular to the distal
tip axis of each lead. Figure 6 displays raw data for each of
our three leads for a scan parallel to the distal tip axis with
the probe tips aligned with the distal tip axis. For measure-
ment of the vector magnitude we only measured two com-
Table 1: Values of the E-field measured near the distal tip of various leads with large probe (no pulse generator connected)
Lead E-ratio
(1 mm from distal tip) large probe
E-width (mm) E-field at probe tip (V/m)
Simulated lead (insulated wire) 3.6 2.5 0.13
Active fixation tip 15.3 7.4 0.54
Tined Tip 18.7 3.2 0.65
Note: See the measurement uncertainty issues" section and the "Alteration of intended therapy by magnetically-induced E-fields" section.BioMedical Engineering OnLine 2009, 8:39 http://www.biomedical-engineering-online.com/content/8/1/39
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ponents of the E-field. Figures 7, 8, and 9 show the vector
magnitude (Eqn. 4) and two individual vector compo-
nents for each lead, measured with a scan perpendicular
to the distal tip axis using the large probe. The probe tip
was scanned so it passed 1 mm from the lead tip at its clos-
est point along the scan path. The line labeled 'edge' indi-
cates the magnitude of the E-field at the edges (outer
diameter) of the tank. This gives perspective on the
enhancement of E at the lead tip relative to the maximum
E in saline without the lead present. Data along this path
provide the "width" of the E-field distribution. We
defined the "width" (E-width) as the distance between
two points along the scan where the value of the E- vector
magnitude was half of the value at the measured maxi-
mum. Table 1 shows E-ratio, E-width and the absolute
value of the E-field 1 mm from each of the three leads with
the large probe. Table 2 compares the E-ratio for each lead
as measured with the large probe versus the small probe.
Injected E-field from Pulse generator
Under normal operation an implantable pacemaker pulse
generator (PG) delivers (injects) voltage pulses to the
saline or surrounding medium at the distal tip of a lead
connected to it. During exposures of an active pacemaker
with a lead to a gradient field, two E- fields are produced
near the lead tip. This occurs whether the lead is in a
patient or in an in-vitro setup. These two E-fields are the
injected plus the magnetically induced fields. We meas-
ured the E- field near the distal tip with the large probe for
two cases, while each of two different pulse generators
were connected during separate experiments to the proxi-
mal end of the active fixation lead, while a 1 kHz magnetic
field was turned on. Two PGs were used in separate exper-
iments, one delivering 0.1 V to the lead and the other
delivering 0.5 V to the lead. The nearest wire of our 2-elec-
trode E- field probe was 1.0 mm from the distal tip of the
lead. The two electrodes of the probe were aligned with
the distal tip axis. Figure 10 shows a time domain plot of
the E-field at this location. When the implantable pace-
maker's pulse generator was delivering a voltage to the
lead, the E-field was a summation of the injected plus the
magnetically induced fields. In addition, during a short
time interval immediately after the PG output voltage
pulse ended, a magnetically induced voltage (1 kHz sine
wave) was still seen. This lasted for about 15 msec after the
end of the pacemaker pulse. This is due to the implantable
pacemaker PG circuitry providing a "recharge interval"
which results in a low input impedance at the pulse gen-
erator implantable pacemaker connection to the proximal
tip of the stimulating lead. No magnetically-induced volt-
age was seen at any other times during the PG output
pulse cycle. This was documented previously [8,12]. Dur-
ing the implantable pacemaker pulse cycle, if a gradient
field pulse is present, the E-field at the distal tip of a stim-
ulating lead is the summation of the injected plus the
magnetically induced fields.
Plots of raw data for the E-field measured while approaching  tips of three leads Figure 6
Plots of raw data for the E-field measured while 
approaching tips of three leads. The scan was parallel to 
the distal tip axis with the probe tips aligned with the distal 
tip axis.
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Table 2: E-ratio for Large probe vs. Small probe
Lead E-ratio Large probe E-ratio Small probe Small probe vs. Large probe
Simulated lead (insulated wire) 3.6 9.5 2.6
Active fixation tip 15.3 22.0 1.6
Tined Tip 18.7 30.4 1.6
Note: See the measurement uncertainty issues" section and the "Alteration of intended therapy by magnetically-induced E-fields" section.BioMedical Engineering OnLine 2009, 8:39 http://www.biomedical-engineering-online.com/content/8/1/39
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In a separate experiment we studied the deformation of
the pacing pulse's waveform in saline by magnetically-
induced E-field we used the maximum magnetic field we
could generate to produce a 4 T/s exposure at 1 kHz. We
monitored the intended stimulation waveform 1 mm
from the distal tip with our probe. The waveform was sig-
nificantly altered (decreased or increased) as shown in fig-
ure 11 during successive output pulses of the implantable
pacemaker. This deformation will occur in clinical situa-
tions when the implantable pacemaker pulse coincides
with the MR gradient pulse. The deformation can be much
greater in clinical situations because a 30 - 100 T/S worst-
case exposure is typical of clinical MR systems. We can lin-
early extrapolate our results from our 4 T/s exposure to
any higher values. This involves taking the ratio of the
clinical MRI system's slew rate versus our slew rate of 4 T/
s. The exception to this is when voltages induced inside a
pacemaker pulse generator circuitry are high enough to
temporarily break down the semiconductor diodes and
circuitry. Then magnetically induced E can occur at any
time during the PG pulse cycle. This is discussed later in
our paper.
Discussion
Measurements of magnetically induced E-fields in different 
leads and with different probe sizes
We measured the magnitude and spatial distribution of
magnetically-induced E-fields near the tips of several
leads. The active fixation lead and the tined tip lead each
had a magnetically-induced E-field whose magnitude was
quite similar at a location 1 mm from the tip. The E-field
strengths for these leads was significantly higher than the
E-field strength induced at the blunt cut tip of a simulated
lead made of an insulated wire. The reason for this dis-
crepancy is not known. This could be due to electrical
properties of the wire, a smaller surface area, or other fac-
tors. The active fixation lead had the smallest tip diameter
(less than 0.2 mm) and produced an E-field that was
broader in distributed area (E-width) than the other leads.
This lead had and E-width of 8.5 mm vs. 3.5 mm for the
tined tip lead and 2.3 mm for the simulated lead. The E-
field magnitude 1 mm from the two pacemaker leads did
not change significantly when measured with the large
(1.6 mm electrode spacing) or the small probe (0.9 mm
electrode spacing). The simulated lead had a measured E-
Measured data for the simulated lead Figure 7
Measured data for the simulated lead. Vector magnitude of E- and 2 vector components measured with a scan perpendic-
ular to the distal tip axis, passing 1 mm from the tip
-20
0
20
40
60
80
100
120
02468 1 0 1
mm
m
i
c
r
o
v
o
l
t
s
2
x axis
y axis
wire Vector Mag
edge
tip locationBioMedical Engineering OnLine 2009, 8:39 http://www.biomedical-engineering-online.com/content/8/1/39
Page 13 of 18
(page number not for citation purposes)
field that was significantly higher when measured 1 mm
from the tip with the small probe. This change when
measuring the E-field near the tip of the simulated lead
must be due to steep spatial gradients in the E-field and
the fact that the measured value is affected by spatial aver-
aging or field perturbation as discussed below.
While we measured E-fields near pacemaker leads, the
methods can be applied to leads of other stimulation
devices such as neural stimulators (spinal cord implants
and deep brain stimulators). This method is non-invasive
in terms of altering the leads or pulse generator under
study.
Measurement uncertainty issues
We assessed measurement uncertainties of E-fields when
the region of interest is extremely close to the tip of a sim-
ulated or actual pacemaker lead. Fields due to magnetic
induction in a lead as well as fields due to voltage-injec-
tion from a pulse generator have large spatial gradients.
For these cases the field being measured has significant
changes in magnitude over a single millimeter (Fig. 6).
There are several sources of uncertainties when measuring
highly localized E-fields with a probe of finite dimen-
sions. These include spatial averaging, field perturbation,
probe positioning, and electromagnetic pickup.
Spatial averaging of the E-field occurs over the region
occupied by our probe tips (1.6 mm or 0.9 mm for the
large and small probes respectively). This averaging pro-
duces a reduction in the measured value of the E-field
with large spatial variations relative to the true value of the
E-field at an infinitesimal point (an underestimation).
The uncertainty is greatest when the distance between the
probe and the lead is on the same order as the probe tip
size. Spatial averaging is not necessarily an undesirable
effect. Clinically significant stimulation is affected by spa-
tial averaging of applied E-fields. In electrically excitable
tissues, stimulation is induced by the average E-field
induced over some finite volume, not an infinitesimally
small point. The measured "true" value of the E-field at an
infinitesimal point can have uncertainties due to spatial
averaging of the E-field by a probe with its two electrodes.
Another measurement uncertainty is due to perturbation
of the E-field by metallic probe electrodes. This uncer-
tainty is greatest when the distance between the probe and
the lead is the same or less than the size of the total probe
Measured data for the active fixation lead Figure 8
Measured data for the active fixation lead. Vector magnitude of E- and 2 vector components measured with a scan per-
pendicular to the distal tip axis, passing 1 mm from the tip
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tip (both electrodes). This perturbation makes the meas-
ured value of the E-field lower than the true value of the
E-field (an underestimation). This uncertainty diminishes
with increasing separation between the probe and the
pacemaker lead tip. The uncertainty from the combina-
tion of spatial averaging and field perturbation was esti-
mated as being 50% at a separation distance that is equal
to the outside dimensions of the total probe tip (1.6 mm
or 0.9 mm for the large and small probes respectively).
The combined uncertainties were determined by compar-
ing the results of scans of the simulated lead with the
small probe versus scans with the large probe. Also, we
performed preliminary calculations of E with computa-
tional electromagnetics software. The results indicated
that the probe's spatial averaging and field perturbation
may produce measurement uncertainties that are greater
than 50%. More validation of the computations must be
performed before conclusions about worst case measure-
ment uncertainties can be finalized.
A third measurement uncertainty occurs due to the error
and repeatability for determining the true position of the
probe tip with respect to a pacemaker lead. This can cause
an underestimation or overestimation. For our mechani-
cal system the positioning error and repeatability is about
0.1 mm. In addition, there is uncertainty due to a lack of
repeatability in placing the probe tip at exactly the same
location with respect to the lead tip being measured. The
resulting uncertainty in the measured E-field value due to
positioning variations is estimated as being 20% at a dis-
tance of 1 mm from the distal tip of the leads we evalu-
ated. This uncertainty diminished as the separation
increases. The estimates of the measurement uncertainties
that are listed above are based on evaluation of spatial
behavior of measured data, consideration of the size of
our probe tips, and comparison of data from large and
small probes. The 3 uncertainties above are common to
measurements of both magnetically-induced E-fields and
the pacemaker injected E-field.
There are additional uncertainties that are unique to the
source of E-fields. For example, for magnetically-induced
E-fields, electromagnetic pickup of the gradient magnetic
field on wires at locations other than the probe tip intro-
duces another uncertainty. Voltages are induced in the
twisted pair of wires between the probe's distal tip and the
Measured data for the tined tip lead Figure 9
Measured data for the tined tip lead. Vector magnitude of E-field and 2 vector components measured with a scan perpen-
dicular to the distal tip axis, passing 1 mm from the tip
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preamplifier in the measurement system. This source of
uncertainty should be identified and minimized. Measur-
ing the E-field along a linear path extending from one
edge of the tank to the other with the path passing
through the center allows observation of this source of
uncertainty. At the center of the saline tank, the measured
voltage should be less than a few percent of the value of
the voltage measured at the outer edges of each side of the
tank. This voltage is measured with no implanted device
lead in the tank, and with the two tips of the probe aligned
with the E-field. Also, the value of the voltage measured at
one side of the tank should be equal the voltage measured
at the other side. This source of uncertainty can cause an
underestimation or overestimation.
It should be noted that the issue of measuring E-fields
with steep spatial variations is not unique to gradient-field
MRI safety of implanted leads. The same issue has chal-
lenged those evaluating the RF-induced heating next to
pacemaker lead tips by radiofrequency (RF) fields of MRI
systems [7,13]. Significant errors in published measured
values of maximum heating (due to E) are well known.
This heating is caused by the magnetically induced E-
fields from RF coils. These RF E-fields have very similar
spatial distribution and fall off to insignificant values
within a few millimeters of implanted leads.
Finally, for assessment of unintended stimulation by mag-
netic induction of E in leads, the effects of each of the
uncertainties discussed above can be minimized or elimi-
nated by determining the ratio of the simultaneous mag-
netically induced versus injected E-fields from an
implantable pacemaker. This approach (comparison of
magnetically induced E-fields versus injected E-fields at a
fixed location near the distal tip) is discussed in the fol-
lowing section.
Alteration of intended therapy by magnetically-induced E-
fields
We compared the magnetically-induced E-fields at the dis-
tal tip of a lead with the "injected" E-field at the tip when
the lead was connected to an active pulse generator of a
Time domain plot of the E-field at the distal tip of a pacemaker lead connected to a pulse generator Figure 10
Time domain plot of the E-field at the distal tip of a pacemaker lead connected to a pulse generator.
-0.05
0
0.05
0.1
0.15
0.2
0.25
0.3
-0.01 0 0.01 0.02 0.03 0.04 0.05
Time (S)
p
t
u
d
e
(
)
Pacemaker 
pulse
Induced E field from a 
4T/sec 1 kHz magnetic field BioMedical Engineering OnLine 2009, 8:39 http://www.biomedical-engineering-online.com/content/8/1/39
Page 16 of 18
(page number not for citation purposes)
cardiac pacemaker. We found that the intended pace-
maker stimulation waveform (injected E-field) is
degraded if a gradient pulse is coincident in time with the
implantable pacemaker output pulse. We demonstrated
the ability of relatively weak gradient fields (< 10 T/s) to
alter therapy significantly. The individual gradient field
pulses subtracted or added to the injected pulse, depend-
ing on their phase with respect to the injected pulse. The
probability of this occurring in a clinical situation
depends on the duration and time of occurrence of gradi-
ent pulses, relative to the occurrence of an implantable
pacemaker pulse. E-fields were induced at the distal tip of
a lead by gradient pulses only when the implantable pace-
maker was delivering a voltage pulse or immediately after
this pulse (within 15 ms). When no implantable pace-
maker pulse was occurring, magnetically induced E-fields
were not present near the lead tip. This is due to the fact
that if both ends of the lead do not have a low-resistance
contact with the saline, then virtually no magnetically-
induced current can flow through the lead to the sur-
rounding medium. When the proximal end of a lead is
connected to a pacemaker pulse generator, a low-resist-
ance path to the surrounding medium is provided by the
electronic circuitry of the implantable pacemaker through
the metallic case of the implantable pacemaker. A low
resistance state in the circuitry occurs when a pulse is
being generated or during an intentional low-impedance
interval of about 10 to 20 ms following the pulse
(depending on the implantable pacemaker design). When
the low-impedance interval ends, the pulse generator cir-
cuitry is in a high resistance state and the E-field at the dis-
tal tip falls to very low levels. It is also possible for very
intense gradient fields (e.g. 50 - 100 T/s) to produce a low-
impedance state in the implantable pacemaker circuitry
when the pacemaker is off. This can occur during non-
destructive breakdown of various electronic components
(e.g. diodes in the input protection circuit). This was dem-
onstrated [12] using a clinical MRI system.
E-field produced by combination of injected voltage from PG and a 4 T/sec magnetic field (1 kHz) Figure 11
E-field produced by combination of injected voltage from PG and a 4 T/sec magnetic field (1 kHz).
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Accurate assessment of the magnetically induced E-field
The comparison of gradient-field/magnetically induced E-
fields versus pulse-generator injected E-fields at a fixed
location near the distal tip provides a powerful method
for assessing gradient induced stimulation with minimal
measurement uncertainties. Simultaneous measurements
of these E-fields allow the determination of the ratio of
the magnitude of these two E-fields with high accuracy.
The ratio eliminates errors due to measurement uncertain-
ties caused by spatial averaging, perturbation of the E-
field, and probe positioning. This elimination of errors
occurs because measurements of each of the two E-fields
have identical uncertainties, biased in the same direction.
Conditions when potentially hazardous stimulation can be 
induced by a gradient field of an MRI system
Magnetically induced E-fields at the distal tip of a unipo-
lar implantable pacemaker lead will usually occur only
during or immediately after the pulse of the device's pulse
generator. The intended stimulation waveform delivered
by an implantable pacemaker pulse generator to a distal
tip unipolar electrode can be significantly altered
(decreased or increased). This is due to magnetically-
induced E-field from a time-coincident MR gradient pulse
combining with the injected pulse from the implantable
pacemaker. Significant variations in the stimulating wave-
form shape were seen with only 4 T/s in experiments per-
formed with our maximum available field (4 T/s). For an
MRI system operating under normal conditions with a 30
to 100 T/s gradient field rate of change, significant
changes in pacemaker stimulation voltages result when a
gradient pulse is coincident (within about 30 ms) with a
implantable pacemaker pulse. For a device other than an
implantable pacemaker that uses long stimulating leads,
similar conditions may exist. The magnitude of the mag-
netically induced E-field will depend on the impedance
presented to the lead by the device's electronics, at the
proximal end of the lead. In addition to the E-field ampli-
tude, the duration and the time of occurrence of the gradi-
ent pulse from a clinical MRI system will determine the
probability of unintended stimulation. The wide range of
MRI sequences available to a clinician has significantly
different duty cycles (percent of the time when a gradient
pulse is generated). Some sequences such as echo planar
imaging can produce continuous gradient pulses with a
very high duty cycle (up to 100%) thus making the coin-
cidence of a gradient pulse and a pacemaker pulse fre-
quent. This could affect several pacemaker stimuli in a
row, potentially canceling therapy delivery.
A simple way to reduce the possibility of unintended stim-
ulation of a patient is to turn off their pacemaker during
an MRI imaging session, provided they are not pacemaker
dependent. This of course opens them to the risk of no
available pacemaker therapy if they were to need it during
the duration of the session.
Future research needs for this work include several issues
Computational modeling of the experimental measure-
ment system is highly desirable to compare with meas-
ured data. In the past, we have been limited in our ability
to obtain reasonable results. The complexity of modeling
a long wire (half a meter in length) and in large volume of
saline becomes challenging when spatial resolution of a
fraction of a millimeter is needed. This resolution is
needed to model the tip and the conductive medium
(saline) next to the tip. Here the E-field decays to insignif-
icant levels a few millimeters from tip, so there are many
cells in a square millimeter that need to be computed.
Finally, the thin insulation layer requires a very large
number of computational cells. Recent improvement in
electromagnetics software and reduced costs should allow
us to perform reasonably accurate modeling and present
them in the near future.
A smaller probe with electrode tip spacing of less than 0.5
mm and fine wires is desirable to reduce measurement
uncertainties from spatial averaging and field perturba-
tion. A smaller probe produces a lower signal and thus
reduces the signal to noise ratio of measurements. This
limits detection of fields farther from the tip than a few
millimeters.
Conclusions
Potentially hazardous situations can exist due to gradient
fields for certain situations. Unintended stimulation can
be induced via abandoned leads if the proximal end is not
"capped" with insulation by the cardiac surgeon. Unin-
tended stimulation can also be induced in leads con-
nected to a pulse generator with loss of hermetic seal at
the connector block of the generator. For properly config-
ured pacemakers the intended stimulation waveform
delivered by a pacemaker pulse generator to a distal tip of
unipolar electrode can be drastically altered (decreased or
increased). This is of particular significance for certain
high duty cycle gradient pulse sequences for pacemaker-
dependent patients. This alteration is due to the magneti-
cally-induced E-field from a time-coincident magnetic res-
onance (MR) gradient pulse. Findings of this work are
applicable to other stimulation device with long
implanted leads with small-area distal tips such as neuros-
timulators.
For bipolar leads, it is possible to recreate this effect for
very high gradient fields (e.g. 100 T/s) due to non-destruc-
tive breakdown of diodes in the pulse generator. This
effect was demonstrated recently [12] in a clinical MR sys-
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